men with advanced prostate cancer could benefit from a pioneering drug originally meant for women . new ‘exciting’ new research suggests the drug , already used to treat women with breast cancer , could also help men with genetic faults within their prostate cancer ( pictured ) tumours . up to 30 per cent of men with advanced prostate cancer have tumours that have dna defects and these respond particularly well to olaparib . they found 16 out of 49 men with advanced prostate cancer responded to the drug , also known as lynparza .